Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 19, 1998

View Archived Issues

Xenova, With Funds To Last Through 1998, Seeks Investors

British Biotech Woes Push UK To Consider Tighter Industry Controls

MorphoSys Changes Partners; Plans Public Offering In '98

Canada To Involve Nation In Debate On Biotech Issues

Display Systems Biotech Seeks Higher US Profile

Amrad Suspends Clinical Trial Of Reformulated Anesthetic

Research Institutes Spawn Many Australian Biotech Firms

French Study Shows Urokinase May Inhibit Growth Of Cancer

Clal Invests $10M In D-Pharm; Takes First Step Into Biotech

Appligène Reports 2Q Sales Increased Over Last Year

European Consumer Group Wants Aggressive GMO Food Labeling

D-Pharm Gets US Patent For Neuroprotective Agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...